Development of a Clinical Risk Score for Prediction of Life-Threatening Arrhythmia Events in Patients with ST Elevated Acute Coronary Syndrome after Primary Percutaneous Coronary Intervention

• Published in: International journal of environmental research and public health Vol. 19; no. 4; p. 1997
• Main Authors: Wongthida, Thanutorn, Lumkul, Lalita, Patumanond, Jayanton, Wongtheptian, Wattana, Piyayotai, Dilok, Phinyo, Phichayut
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10-02-2022; MDPI
• Subjects: Acute coronary syndromes; Angioplasty; Arrhythmia; Cardiac arrhythmia; Complications; Desaturation; Fibrinolysis; Heart attacks; Heart failure; Hemoglobin; Hospitals; Intubation; Laboratories; Mortality; Patients; Reperfusion; Respiratory failure; Risk assessment; Vital signs; life threatening arrhythmia; risk assessment; ST Elevation Myocardial Infarction; primary percutaneous coronary intervention
• ISSN: 1660-4601; 1661-7827; 1660-4601
• DOI: 10.3390/ijerph19041997

ST-elevated acute coronary syndrome (STEACS) is a serious condition requiring timely treatment. Reperfusion with primary percutaneous coronary intervention (pPCI) is recommended and preferred over fibrinolysis. Despite its efficacy, lethal complications, such as life-threatening arrhythmia (LTA), are common in post-PCI patients. Although various risk assessment tools were developed, only a few focus on LTA prediction. This study aimed to develop a risk score to predict LTA events after pPCI. A risk score was developed using a retrospective cohort of consecutive patients with STEACS who underwent pPCI at Chiangrai Prachanukroh Hospital from January 2012 to December 2016. LTA is defined as the occurrence of malignant arrhythmia that requires advanced cardiovascular life support (ACLS) within 72 h after pPCI. Logistic regression was used for model derivation. Among 273 patients, 43 (15.8%) developed LTA events. Seven independent predictors were identified: female sex, hemoglobin < 12 gm/dL, pre- and intra-procedural events (i.e., respiratory failure and pulseless arrest), IABP insertion, intervention duration > 60 min, and desaturation after pPCI. The LTA score showed an AuROC of 0.93 (95%CI 0.90, 0.97). The score was categorized into three risk categories: low (<2.5), moderate (2.5-4), and high risk (>4) for LTA events. The LTA score demonstrated high predictive performance and potential clinical utility for predicting LTA events after pPCI.